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CASE REPORT / OLGU SUNUMU 
Eccrine porocarcinoma: A case report and literature review
Ekrin porokarsinoma: Olgu sunumu ve literatür taraması
Deniz Arslan1, Ali Murat Tatlı1, Mükremin Uysal1, Muhammet Ali Kaplan2
ÖZET
Ekrin porokarsinoma ter bezlerinin nadir görülen bir tümö-
rüdür. Daha çok yaşlılarda gözlenir ve alt ekstremiteleri 
tutma eğilimindedir. Ana tedavi yöntemi cerrahi eksizyon-
dur ve lokal ve uzak nüksler gösterebilir. Kemoterapi ve 
radyoterapinin etkisi çelişkilidir. Biz burada 90 yaşında ka-
dın hastada aksillar bölgede lokalize ekrin porokarsinoma 
vakasını mevcut literatür eşliğinde sunduk.
Anahtar kelimeler: Ekrin porokarsinoma, kemoterapi, 
aksilla
ABSTRACT
Eccrine porocarcinoma is a rarely seen malignant tumor 
of the sweat glands. It is commonly seen in elderly people 
and it tends to involve lower extremities. Surgical exci-
sion is the main therapeutic modality. It may show local 
recurrences and systemic metastasis. The effects of che-
motherapy and radiotherapy are contradictory. Here, we 
present a case of 90-years-old female patient with eccrine 
porocarcinoma localized in the axillary area and addition-
ally we review the existing literature. J Clin Exp Invest 
2013; 4 (3): 370-373
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INTRODUCTION
Eccrine porocarcinoma (EPC) is a rare malignant 
tumor of the sweat glands. It has initially been de-
scribed as “epidermotropic eccrine carcinoma” by 
Pinkus and Mehregan in 1963 and later described 
as “eccrine porocarcinoma” by Mishima and Morika 
in 1969 [1,2]. It accounts for a very small part of the 
epithelial cutaneous cancers. This tumor originates 
from the intraepithelial parts of the sweat glands [3]. 
It commonly originates from lower extremity, espe-
cially in the elderly patients [4]. Here, we present a 
case of axillary eccrine porocarcinoma.
CASE REPORT
A 90-years-old female patient was brought to the 
emergency  department  with  complaints  including 
palpitations, shortness of breath and a swelling 
with discharge in the right axilla, which have been 
sustained for 4-5 days. Except for bilateral pleural 
fluid, bilateral passive atelectasia in the pulmonary 
parenchyma, cardiomegaly and a mass of approxi-
mately 4x5 cm in the right axillary fossa with several 
nodules in its contiguity, Thoracic computerized to-
mography revealed no pathologic findings (Figure 
1). The patient who showed atrial fibrillation signs in 
the electrocardiography had an ejection fraction of 
60%. After the first and also the second biochemi-
cal, cytological examination of pleural fluid, It was 
found that pleural fluid had transudate characteris-
tics, did not contain atypical cells and was adenos-
ine deam inase negative. No microbiological growth 
was observed. In terms of tuberculosis, after the two 
consecutive  sputum  sampling  it  was  shown  that, 
the sputum was negative for acid-resistant bacteria 
(the sputum was sampled for two times at one-day 
interval and it was shown that there were no acid 
resistant bacteria). The patient was diagnosed as 
hyperthyroiditic and initiated to be given anti-thyroid 
therapy. In the excisional biopsy obtained from the 
right axillary lymphadenopathy, the nesting tumor 
consisted of the cells with coarse hyperchromatic 
nucleus and eosinophilic cytoplasma was observed. 
In the cells, periodic acid-schiff (PAS) and diastase 
periodic acid-schiff (d-PAS) stain-positive granules 
were found (Figure 2). Pathological diagnosis was 
reported  as  primary  eccrine  porocarcinoma. After 
the evaluation of Radiological, clinical and patho-
logical findings the diagnose was right axillary re-
gion  originated  locally  primary  eccrine  porocarci-
noma. ec Upon the recurrence of pleural effusion in Arslan et al. Eccrine porocarcinoma 371
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her follow-ups, a chest tube was placed into the left 
hemithorax of the patient who developed hypoxia. 
The patient demonstrated alterations in conscience, 
but magnetic resonance images of the brain did not 
show any findings consistent with metastasis. Upon 
the regression of Karnofsky performance status to 
20%,  surgical  therapy,  radiotherapy  or  systemic 
therapy was not given during follow-up and the pa-
tient died in the second month of the follow-up due 
to sepsis resulting from intercurrent infections.
Figure 1. In the thoracic CT sections, bilateral pleural fluid, passive atelectasia in bilateral pulmonary parenchyma, and 
a mass of approximately 4x5 cm in the right axillary fossa with several nodules in its contiguity (arrow) can be seen, 
more markedly in the right side.
Figure 2. In the sections, a necrotic area is observed in 
the center of the cell groups with coarse and hyperchro-
matic nucleus and marked nucleolus (HEx100)
DISCUSSION
Eccrine porocarcinoma is a rarely seen tumor of the 
sweat glands. It accounts for 0.005% to 0.01% of all 
skin cancers. Since the first published case in 1963 
to date, in the literature, approximately 250 case 
reports have been presented [5]. While its age of 
onset ranges between 40 and 80 years, mean age 
is 58,5 and it equally affects both genders [6,7]. Ec-
crine poroma is seen with sebaceous nevus, chron-
ic lymphocytic leukemia and malign transformation 
of the actinic lesions or as de novo, as seen in many 
cases [8]. Generally, EPC occurs as a single, as-
ymptomatic,  solitary  nodule,  plate  and  ulcerative 
lesion [9]. Although the pathogenesis and eventual 
pre-invasive markers of EPC are unknown, accord-
ing to the reports of some authors in the literature, 
predisposing factors include exposure of the skin to 
burning, trauma or radiotherapy, immunosuppres-
sive therapies  administered  after the transplanta-
tion (kidneys, heart), AIDS and prolonged exposure 
to ultraviolet light [9,10]. Although it is mostly seen 
in the lower extremities (50%), it is also seen in the 
trunk (24%), in the head-neck area (18%), in the up-
per extremities, in the hands, in the vulva, in the pe-
nis, in the pubis and in the abdomen [11,12]. While 
local metastasis and lymph node metastasis were 
reported in 20% of the cases, the metastases of 
visceral organs (lungs, liver, bladder, adrenal gland, 
peritoneum) and bone was reported in 10% of the 
cases [13]. Based on case series, in the presence 
of metastases, the mortality rate reaches 80% [13]. 
Important histological prognostic factors include the 
depth of the tumor, the number of mitosis and lym-
phovascular invasion [13]. In our case, there was 
no history of primary lesion. It was observed as a Arslan et al. Eccrine porocarcinoma 372
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single, ulcerated and running lesion in the axillary 
area, which is a rarely involved area.
In the differential diagnosis, basal and squa-
mous cell carcinomas, seborrheic keratosis, amela-
notic melanoma, verruca vulgaris, cutaneous lym-
phoma, skin metastases of different types of cancer 
and other diseases such as Bowen, Paget, hydro-
acanthoma simplex should be considered [14]. 
Histologically, majority of the eccrine porocar-
cinoma cases have acanthoic epidermis associated 
to neoplastic poromatous epithelial cell islets that 
invade the dermis. Neoplastic cells have dispersed-
ly hyperchromatic mitotic large nucleus. These cells 
may  be  basophilic  and  may  show  clear  cell  dif-
ferentiation [15]. Its histological diagnosis may be 
complicated.  The  study  conducted  by  Robson  et 
al. on a case series of 69 patients highlighted the 
importance of knowing eccrine ducts. Furthermore, 
they reported that, if taken as the essential criterion 
for the diagnosis, some poorly differentiated tumors 
might be missed [13]. Because of the staining of 
ECP cells with carcinoembryonic antigen (CEA), the 
lumens and the cytoplasms of the malignant sweat 
glands are mostly demonstrated. The cells located 
in the ductus lumen are characteristically deprived 
of keratin and, as glycogen granules are numerous 
in the cytoplasm of all cells, they may be easily seen 
using PAS [15]. Positive staining with PAS/d-PAS 
and/or  CEA/EMA  (epithelial  membrane  antigen) 
may also be detected without the observation of ec-
crine ducts under light microscope [16]. 
The treatment consists of large local excision 
of the primary lesion and it may be cured in 70-80% 
of the cases [17]. There are some publications that 
reported the absence of recurrence in the 5-year 
follow-up using Mohs microsurgery technique [18]. 
In the literature, there is not enough data to sup-
port adjuvant therapy (chemotherapy/radiotherapy) 
and  the  methods  such  as  cryosurgery  and  elec-
trosurgery for the prevention of tumor recurrence 
[9,10]. Regional lymph node metastasis is detected 
in 20% of the cases [10]. If there is dissemination 
to regional lymph nodes, regional lymph node dis-
section should be performed [19]. In these cases, 
the mortality rate was reported to be 67%. Sentinel 
lymph node biopsy may be helpful to determine the 
presence of subclinical metastasis in the regional 
lymph nodes [20]. Bogner et al. performed sentinel 
lymph node dissection in five patients, one of which 
was with salivary gland carcinoma diagnosed with 
eccrine  porocarcinoma,  and  they  detected  lymph 
node metastasis in three patients [21]. More rarely, 
distant metastasis may also be seen in the patients 
diagnosed  with  eccrine  porocarcinoma  [22].  Due 
to the predisposition to local recurrence and me-
tastasis, close post-operative follow-up is required 
[12]. Very few or partial response was obtained us-
ing methotrexate, cisplatin, vincristine, prednisolon, 
adriamycine,  bleomycine,  isotretionine,  interferon 
alpha,  interleukine-2,  5-fluorouracil  and  docetaxel 
[9,11,12]. Da Silva and Bleir obtained successful re-
sults using post-operative radiotherapy [23]. 
As seen in our case, for the patients with an 
axillary mass, large local excision and axillary lymph 
node dissection may be recommended [16]. How-
ever, in our patient, additional clinical problems re-
sulting from low performance following the biopsy 
prevented the administration of the surgical therapy. 
In these patients, there is no adequate data to show 
the place of radiotherapy in the adjuvant, prophy-
lactic and palliative therapies. Therefore, palliative 
radiotherapy was not considered.
Consequently, as EPC is a very rarely seen tu-
mor of the sweat glands, there are not so many ac-
tual data in the literature that evaluate different ther-
apeutic modalities and their outcomes. As it may be 
mixed up with other benign and malignant lesions of 
the skin based on the results of few series reported 
in the literature, it may be stated that its diagnosis 
may be complicated, that despite the lack of a com-
plete surgical margin, its primary therapy is surgery, 
and that the place of chemotherapy and radiother-
apy is contradictory. As EPC has a poor prognosis, 
shows different biological behaviors and especially 
has the risk for local-regional recurrence and distant 
metastasis, it should be closely monitored.
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